Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jun;85(6):1380-1381.
doi: 10.1111/bcp.13924. Epub 2019 Apr 13.

Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al

Solène M Laville  1 , Bénédicte Stengel  1 , Ziad A Massy  1   2 , Sophie Liabeuf  3
Affiliations
Comment

Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al

Solène M Laville et al. Br J Clin Pharmacol. 2019 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no competing interests to declare.

Comment on

References

    1. Stamp LK, Wright DFB, Dalbeth N. Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate! Br J Clin Pharmacol. 2019;85(6):1378‐1379. - PMC - PubMed
    1. Laville SM, Metzger M, Stengel B, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD‐REIN cohort. Br J Clin Pharmacol. 2018;84(12):2811‐2823. 10.1111/bcp.13738 - DOI - PMC - PubMed
    1. Stengel B, Metzger M, Combe C, et al. Risk profile, quality of life and care of patients with moderate and advanced CKD. The French Chronic Kidney Disease—Renal Epidemiology and Information Network (CKD‐REIN) Cohort Study. Nephrol Dial Transplant. 2018;34(2):277‐286. - PubMed
    1. Yang C‐Y, Chen C‐H, Deng S‐T, et al. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population‐based study in Taiwan. JAMA Intern Med. 2015;175(9):1550‐1557. 10.1001/jamainternmed.2015.3536 - DOI - PubMed
    1. Chaby G, Valeyrie‐Allanore L, Duong TA, et al. Severe cutaneous adverse reactions due to inappropriate medication use. Br J Dermatol. 2018;179(2):329‐336. 10.1111/bjd.16365 - DOI - PubMed